Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Helps protect cells from oxidative stress
hypertension, type 2 DM, dyslipidemia) A meta-analysis of 22 trials involving over 17,000 patients determined that 50.2% and 17.5% of patients treated with GLP-1RAs (exenatide, semaglutide & liraglutide) experienced a weight loss of 5% and 10% compared to placebo, and that patients without type 2 diabetes achieved a significantly greater weight loss compared to those with diabetes (Vosoughi et al, 2022)
Higgins JP, Savovic J, Page MJ, Sterne JA, Development Group for RoB 2.0
On this note, we also observed a lack of studies examining possible interactions between psychotropic medications and GLP-1RAsperhaps due to the novelty of the latter
Milk-based MRPs could protect against oxidative damage and reduce cardiovascular risks 631
Simon et al
